Sign in
4

Changes in Ownership

PALISADE BIO, INC. Filed Acc 0001493152-23-042663

CEO, CFO, Director acquired 10,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Finley John David CEO, CFO, Director 2023-11-20 Grant or award +10,000 $0.51 $5,100 57,781 D
Derivatives
Finley John David CEO, CFO, Director 2023-11-21 Grant or award · Restricted Stock Units +38,000 38,000 D
Finley John David CEO, CFO, Director 2023-11-21 Grant or award · Common Stock Options +45,000 45,000 D
Loading xslF345X05/ownership.xml…